Search research articles
Contact Us
Filters
Showing results (41-50 of 77) with videos related to
Page
of 8
Sort By:
Journal of Clinical Medicine
|
April 13, 2023
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
Natalie K Heater, Scott Okuno, Steven Robinson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2020
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy
Angela C Hirbe, Vanessa Eulo, Chang I Moon, et al.
The Lancet. Oncology
|
June 9, 2020
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean-Yves Blay, César Serrano, Michael C Heinrich, et al.
Rare Tumors
|
August 13, 2015
Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma
Steven Attia, Scott H Okuno, Steven I Robinson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study
Steven Attia, Anne M Traynor, Kyungmann Kim, et al.
The Lancet. Oncology
|
January 19, 2026
Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trial
Varun Monga, Scott Okuno, Brian Van Tine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2021
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous <i>KIT/PDGFRA</i> Mutations in the Phase III INVICTUS Study
Sebastian Bauer, Michael C Heinrich, Suzanne George, et al.
JAMA Oncology
|
March 31, 2022
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial
Robin L Jones, Vinod Ravi, Andrew S Brohl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial
Ravin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Cancer Medicine
|
August 11, 2022
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
Steven Attia, Vanessa Bolejack, Kristen N Ganjoo, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 77) with videos related to
Sort By:
Page
of 8
Journal of Clinical Medicine
|
April 13, 2023
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
Natalie K Heater, Scott Okuno, Steven Robinson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2020
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy
Angela C Hirbe, Vanessa Eulo, Chang I Moon, et al.
The Lancet. Oncology
|
June 9, 2020
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean-Yves Blay, César Serrano, Michael C Heinrich, et al.
Rare Tumors
|
August 13, 2015
Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma
Steven Attia, Scott H Okuno, Steven I Robinson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study
Steven Attia, Anne M Traynor, Kyungmann Kim, et al.
The Lancet. Oncology
|
January 19, 2026
Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trial
Varun Monga, Scott Okuno, Brian Van Tine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2021
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous <i>KIT/PDGFRA</i> Mutations in the Phase III INVICTUS Study
Sebastian Bauer, Michael C Heinrich, Suzanne George, et al.
JAMA Oncology
|
March 31, 2022
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial
Robin L Jones, Vinod Ravi, Andrew S Brohl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial
Ravin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Cancer Medicine
|
August 11, 2022
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
Steven Attia, Vanessa Bolejack, Kristen N Ganjoo, et al.
Page
of 8